Novo Nordisk A S

NVONYSE Denmark Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$174.460 B

$39.40 -1.00%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#6AstrazenecaAZN$261.1B
#7Abbott LaboratoriesABT$179.4B
#8Novo Nordisk A SNVO$174.5B
#9PfizerPFE$159.2B
#10Vertex PharmaceuticalsVRTX$130.5B

What if Novo Nordisk A S were worth as much as…

Open the what-if tool →

Gold $30.2T

$6,828.01

Per share 173× higher

Bitcoin $1.74T

$393.33

Per share 9.98× higher

Nvidia $5.52T

$1,245.68

Per share 31.6× higher

Or at a round number

$500.0B $1.00T $2.00T $5.00T

Where these numbers come from

Share counts and financials for Novo Nordisk A S are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.